The Parkinsons

Mike Fox introduces a travel book narrating his wife’s treatment for Parkinson’s disease in Italy

Retrieved on: 
Wednesday, September 2, 2020

TORQUAY, England, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Author Mike Fox offers a travel book/autobiography advocating awareness for Parkinsons disease.

Key Points: 
  • TORQUAY, England, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Author Mike Fox offers a travel book/autobiography advocating awareness for Parkinsons disease.
  • It takes readers to the life of a person living with Parkinsons disease from the treatments to the therapies.
  • There are over 10 million people who are living with Parkinsons disease worldwide, according to the Parkinsons Foundation.
  • I want Parkinson's [patient] to be encouraged; I want everyone to be more aware of the disease; and hopefully my readers will enjoy my travels and observations of Italy, Fox says.

Parkinson’s Foundation Hosts Spanish-Language Conference for People Living With Parkinson’s Disease, Care Partners, Healthcare Community

Retrieved on: 
Tuesday, September 24, 2019

The conference, led by a noted line up of expert physicians and advocates, is specifically designed for Hispanics and Spanish-speakers living with Parkinsons disease (PD), their care partners, and the general healthcare community.

Key Points: 
  • The conference, led by a noted line up of expert physicians and advocates, is specifically designed for Hispanics and Spanish-speakers living with Parkinsons disease (PD), their care partners, and the general healthcare community.
  • The event is completely free and open to the public, but registration is required at parkinson.org/conferencia or by calling the bilingual Parkinsons Foundation Helpline at 1-800-4PD-INFO (473-4636).
  • Special guest Sebastian Krys, a five-time Grammy and 12-time Latin Grammy award winner, will speak about living with Parkinsons.
  • The Parkinsons Foundation makes life better for people with Parkinsons disease by improving care and advancing research toward a cure.

Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL151 for Parkinson’s Disease and Launch of Its Engage Parkinson’s Website

Retrieved on: 
Wednesday, September 4, 2019

LRRK2 is a regulator of lysosomal function, which is impaired in Parkinsons disease and may be restored by LRRK2 inhibition.

Key Points: 
  • LRRK2 is a regulator of lysosomal function, which is impaired in Parkinsons disease and may be restored by LRRK2 inhibition.
  • Inhibition of LRRK2 activity may potentially slow the progression of disease in all patients with Parkinsons disease based on restoration of lysosomal function.
  • The launch of our Engage Parkinsons website is intended to strengthen our engagement and interactions with the Parkinsons disease patient community.
  • EngageParkinsons.com The Denali Parkinsons disease patient engagement website provides patients, caregivers, healthcare professionals, and advocates an online destination for emerging information about Parkinsons disease.

ACADIA Pharmaceuticals Supports Parkinson’s Disease Awareness Month and World Parkinson’s Day with Local Educational Initiatives and Community Events Across the Country

Retrieved on: 
Thursday, April 11, 2019

ACADIA is committed to supporting the Parkinsons community and increasing awareness about Parkinsons disease (PD) and Parkinsons disease psychosis (PDP), a progressive and debilitating non-motor condition characterized by hallucinations and delusions related to PD.

Key Points: 
  • ACADIA is committed to supporting the Parkinsons community and increasing awareness about Parkinsons disease (PD) and Parkinsons disease psychosis (PDP), a progressive and debilitating non-motor condition characterized by hallucinations and delusions related to PD.
  • This April, in honor of Parkinsons Awareness Month and World Parkinsons Day, we encourage patients and their families to attend an event, which includes important resources to help them navigate their unique journey with Parkinsons.
  • Optimism Walks hosted by the American Parkinsons Disease Association across the country aim to turn the Parkinsons communitys passion and concern about Parkinsons into a positive experience that raises awareness of the disease.
  • About one million people in the United States and from four to six million people worldwide suffer from Parkinsons disease.